Shaikh Khalifa Medical City is a tertiary care medical center, in Abu Dhabi, United Arab Emirates. It is administered by the Abu Dhabi General Health Authority.
The hospital initially opened its doors to the 1st patients on February 28, 2000, under the direct management of a Canadian company, InterHealth Canada, under the auspices of the General Health Authority. Its initial name was the Shaikh Khalifa Medical Center (SKMC). In 2005, it grew exponentially by merging with 2 adjacent facilities, the Central Hospital(demolished now), and the Al Jazeerah Hospital(name changed to medical pavilion under skmc ), and became the Shaikh Khalifa Medical City.
It has close to 600 acute medical beds, and offers a wide variety of Western-style medical and surgical treatment and diagnostic facilities.
One of the original aims in setting up SKMC was to provide a high-quality international standard-of-care facility so that local Emirati patients would not have to travel out of the country to Europe or North America for their medical treatments. Subsequently, the facility was expanded to accommodate the treatment of non-local patients where adequate care was not available elsewhere. In 2011, the position of Chief Executive Officer for the facility was given Dr. [[Jeff Staples]. Dr. Staples brings 15 years of healthcare management experience to SKMC, most recently serving as Group Senior Vice President of Asia Pacific Health Partners in China where he specialized in business development, strategy and planning; healthcare systems design and integration; healthcare operations; and Joint Commission International preparations. He earned his medical degree from Columbia University in 1993 and his masters in business administration from San Francisco State University in 1989. | publisher = arabianbusiness.com | date = 02 October 2007 | url = http://www.arabianbusiness.com/501301-dr-business | accessdate = 2009-11-12 }}</ref>[1] While CEO, Ouriel initiated a controversial move to disclose hospital data online which would allow people to get a "snapshot of the facility's clinical strengths and weaknesses"; Ouriel favored transparency.[2]